Centro de Investigación Biomédica en Red de Cáncer-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2023

  1. Post-transcriptional control of a stemness signature by RNA-binding protein MEX3A regulates murine adult neurogenesis

    Nature Communications, Vol. 14, Núm. 1

  2. Posttranslational splicing modifications as a key mechanism in cytarabine resistance in acute myeloid leukemia

    Leukemia, Vol. 37, Núm. 8, pp. 1649-1659

2022

  1. Free triiodothyronine levels and age influences the metabolic profile and COVID-19 severity parameters in euthyroid and levothyroxine-treated patients

    Frontiers in Endocrinology, Vol. 13

  2. IKKα Induces Epithelial–Mesenchymal Changes in Mouse Skin Carcinoma Cells That Can Be Partially Reversed by Apigenin

    International Journal of Molecular Sciences, Vol. 23, Núm. 3

  3. Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment

    Journal of Clinical Investigation, Vol. 132, Núm. 7

  4. Tunable gold nanorod/NAO conjugates for selective drug delivery in mitochondria-targeted cancer therapy

    Nanoscale, Vol. 14, Núm. 22, pp. 8028-8040

2021

  1. Cyld inhibits the development of skin squamous cell tumors in immunocompetent mice

    International Journal of Molecular Sciences, Vol. 22, Núm. 13

2018

  1. Enhanced cytotoxic activity of mitochondrial mechanical effectors in human lung carcinoma H520 cells: Pharmaceutical implications for cancer therapy

    Frontiers in Oncology, Vol. 8, Núm. NOV

  2. Low-dose statin treatment increases prostate cancer aggressiveness

    Oncotarget, Vol. 9, Núm. 2, pp. 1494-1504